Clinical Trial Update: A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression [Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 2 study evaluating add-on oral slow-release ketamine for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (oral slow-release) add-on (ketamine)

Snippet

Sponsor: Daniel Lindqvist | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: RECRUITING